Equity Profile

ICUI

ICU Medical, Inc.

Health CareHealth Care Supplies$4.6B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly for infusion therapy and critical care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly for infusion therapy and critical care. With a market cap of $5 billion, it plays a crucial role in providing essential healthcare supplies, especially as demand for medical equipment continues to grow in the healthcare sector.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1 2026, ICU Medical reported an EPS of $1.97, significantly beating expectations by 48.12%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for ICU Medical are cautiously optimistic, given its strong earnings history. Investors are looking for continued growth and profitability.

Bull Case

If ICU Medical continues its trend of beating EPS estimates, it could see significant stock appreciation as confidence in its growth story strengthens.

Bear Case

Conversely, any signs of slowing revenue growth or failure to meet expectations could lead to a negative market reaction, especially given the high valuation.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong history of beating EPS estimates, this number will be crucial for investor confidence and stock performance.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to assess the company's ability to maintain its market position and drive future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ICU Medical's ability to maintain its growth trajectory, especially given its recent strong earnings performance.

Supporting Evidence

ICU Medical has consistently beaten EPS estimates, suggesting strong operational performance.

The options market is pricing a larger move than the historical average, indicating heightened expectations.

The company's focus on critical care products positions it well in a growing healthcare market.

Key Risk

If the EPS comes in below $1.50, it could undermine the bullish sentiment and lead to a reevaluation of growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers on whether ICU Medical can sustain its impressive earnings growth in a competitive healthcare market.

Bull Confirmed If

An EPS of $2.00 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.50 would raise concerns about the company's growth trajectory and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of about 5.31%, indicating that traders expect some volatility around the earnings report.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.7%, with a raw directional average of +3.1% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests the stock could rise by about 0.93% on average, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await more guidance from management.

Miss

Should the company miss expectations, history indicates a potential decline of around 2.40%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Insights into market demand for infusion therapy products.
3Management's outlook on revenue growth for the upcoming quarters.
4Comments on competitive pressures and how the company plans to address them.
5Any changes in guidance or strategic priorities moving forward.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in developing and manufacturing medical devices, particularly for infusion therapy and critical care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1 2026, ICU Medical reported an EPS of $1.97, significantly beating expectations by 48.12%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for ICU Medical are cautiously optimistic, given its strong earnings history. Investors are looking for continued growth and profitability.

Bull Case

If ICU Medical continues its trend of beating EPS estimates, it could see significant stock appreciation as confidence in its growth story strengthens.

Bear Case

Conversely, any signs of slowing revenue growth or failure to meet expectations could lead to a negative market reaction, especially given the high valuation.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong history of beating EPS estimates, this number will be crucial for investor confidence and stock performance.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to assess the company's ability to maintain its market position and drive future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ICU Medical's ability to maintain its growth trajectory, especially given its recent strong earnings performance.

Supporting Evidence

ICU Medical has consistently beaten EPS estimates, suggesting strong operational performance.

The options market is pricing a larger move than the historical average, indicating heightened expectations.

The company's focus on critical care products positions it well in a growing healthcare market.

Key Risk

If the EPS comes in below $1.50, it could undermine the bullish sentiment and lead to a reevaluation of growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers on whether ICU Medical can sustain its impressive earnings growth in a competitive healthcare market.

Bull Confirmed If

An EPS of $2.00 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.50 would raise concerns about the company's growth trajectory and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of about 5.31%, indicating that traders expect some volatility around the earnings report.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests the stock could rise by about 0.93% on average, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await more guidance from management.

Miss

Should the company miss expectations, history indicates a potential decline of around 2.40%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Insights into market demand for infusion therapy products.
3Management's outlook on revenue growth for the upcoming quarters.
4Comments on competitive pressures and how the company plans to address them.
5Any changes in guidance or strategic priorities moving forward.